Class II recall: Apollo Care, LLC: SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Sub

The FDA classified as Class II a recall by Apollo Care, LLC of Semaglutide 6.75mg (4.5 mg/mL) 1.5 mL sterile multi-dose vials, NDC 71170-821-01, intended for subcutaneous injection. The recall was initiated due to the presence of particulate matter, identified as nylon/polyamide and silk/proteinaceous-type material, according to the FDA notice.

Most relevant for: Patients with diabetes or obesity who have received semaglutide injections from the recalled Apollo Care, LLC multi-dose vials

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.